EcoDrugPlus

Protein Kinase C Zeta

Ensembl ID : ENSOPRG00000014041
Gene Symbol: PRKCZ
1 Cross references
201 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSOPRG00000017023
Gene Symbol: PRKD1
1 Cross references
204 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSOPRG00000008233
Gene Symbol: PRKD3
1 Cross references
270 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Alpha

Ensembl ID : ENSOPRG00000007574
Gene Symbol: PRKACA
1 Cross references
283 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSOPRG00000010726
Gene Symbol: PRKDC
1 Cross references
184 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSOPRG00000005414
Gene Symbol: PPP3CA
1 Cross references
229 Possible Orthologues:

Protein Tyrosine Kinase 2

Ensembl ID : ENSOPRG00000013154
Gene Symbol: PTK2
1 Cross references
326 Possible Orthologues:

Protein Tyrosine Kinase 2 Beta

Ensembl ID : ENSOPRG00000000522
Gene Symbol: PTK2B
1 Cross references
269 Possible Orthologues:

Protein Tyrosine Phosphatase Non-Receptor Type 11

Ensembl ID : ENSOPRG00000011811
Gene Symbol: PTPN11
1 Cross references
251 Possible Orthologues:

Protein Tyrosine Phosphatase Receptor Type B

Ensembl ID : ENSOPRG00000002668
Gene Symbol: PTPRB
1 Cross references
264 Possible Orthologues:

Purine Nucleoside Phosphorylase

Ensembl ID : ENSOPRG00000017080
Gene Symbol: PNP
1 Cross references
429 Possible Orthologues:

Purinergic Receptor P2x 3

Ensembl ID : ENSOPRG00000003827
Gene Symbol: P2RX3
1 Cross references
270 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).